摘要

Our in vitro studies revealed that a transcription factor, Forldiead box protein O1 (FoxO1), negatively regulates the expression of Na(v)1.5, a main et subunit of the cardiac Na+ channel, by altering the promoter activity of SCN5a in HL-1 cardiomyocytes. The in vivo role of FoxO1 in the regulation of cardiac Na(v)1.5 expression remains unknown. The present study aimed to define the role of FoxO1 in the regulation of Na(v)1.5 expression and cardiac Na+ channel activity in mouse ventricular cardiomyocytes and assess the cardiac electrophysiological phenotype of mice with cardiac FoxO1 deletion. Tamoxifen-induced and cardiac-specific FoxO1 deletion was confirmed by polymerase chain reaction (PCR). Cardiac FoxO1 deletion failed to result in either cardiac functional changes or hypertrophy as assessed by echocardiography and individual ventricular cell capacitances, respectively. Western blotting showed that FoxO1 was significantly decreased while Na(v)1.5 protein level was significantly increased in mouse hearts with FoxO1 deletion. Reverse transcription-PCR (RT-PCR) revealed that FoxO1 deletion led to an increase in Na(v)1.5 and Na+ channel subunit 133 mRNA, but not beta 1, 2, and 4, or connexin 43. Whole patch-clamp recordings demonstrated that cardiac Na+ currents were significantly augmented by FoxO1 deletion without affecting the steady-state activation and inactivation, leading to accelerated depolarization of action potentials in mouse ventricular cardiomyocytes. Electrocardiogram recordings showed that the QRS complex was significantly shortened and the P wave amplitude was significantly increased in conscious and unrestrained mice with cardiac FoxO1 deletion. Na(v)1.5 expression was decreased in the pen-infarct (border-zone) of mice with myocardial infarction and FoxO1 accumulated in the cardiomyocyte nuclei of chronic ischemic human hearts. Our findings indicate that FoxO1 plays an important role in the regulation of Na(v)1.5 and 133 subunit expressions as well as Na+ channel activity in the heart and that FoxO1 is involved in the modulation of Na(v)1.5 expression in ischemic heart disease.

  • 出版日期2014-9